Pretika Corporation

Pretika Corporation designs and produces three primary types of medical devices: ultrasonic skin surface treatment units for non-invasive skin rejuvenation, transcutaneous electrical stimulation leads for muscle or nerve therapy, and pneumatic massagers for home-use mechanical relief of muscle tension. These devices are developed to address specific therapeutic needs in aesthetics and physical therapy.

Pretika Corporation is based in the United States, which means its devices fall under FDA jurisdiction. The FDA classifies Pretika’s products as either Class I or Class II, depending on their risk level and intended use. This classification determines the regulatory pathway—such as 510(k) premarket notifications or UDI (Unique Device Identification) requirements—required for authorisation.

Pretika Corporation’s devices are listed in the FDA’s regulatory databases, specifically through the 510(k) pathway for certain products and via UDI (Unique Device Identification) requirements. These registries ensure traceability and compliance with U.S. medical device regulations, allowing healthcare providers and regulators to verify device details and authorisation status.

Pretika Corporation’s devices are classified as either Class I or Class II under FDA regulations. Class I devices generally pose minimal risk and may require general controls, while Class II devices involve moderate risk and require special controls to ensure safety and effectiveness. This classification influences the regulatory pathway (e.g., 510(k) submissions for Class II) and ensures appropriate oversight based on the device’s potential impact on patient health.